The University of Chicago Header Logo

Connection

Richard Whitley to Acyclovir

Back to Details
This is a "connection" page, showing publications Richard Whitley has written about Acyclovir.
Richard Whitley
Connection Strength
5.585
Acyclovir
  1. The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
    View in: PubMed
    Score: 0.404
  2. HSV shedding. Antiviral Res. 2004 Aug; 63 Suppl 1:S19-26.
    View in: PubMed
    Score: 0.241
  3. HSV-2 transmission. Antiviral Res. 2004 Aug; 63 Suppl 1:S27-35.
    View in: PubMed
    Score: 0.241
  4. Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004 Jun; 17(3):243-6.
    View in: PubMed
    Score: 0.238
  5. Herpes simplex virus infection. Semin Pediatr Infect Dis. 2002 Jan; 13(1):6-11.
    View in: PubMed
    Score: 0.201
  6. Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
    View in: PubMed
    Score: 0.164
  7. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group. Antimicrob Agents Chemother. 1998 May; 42(5):1139-45.
    View in: PubMed
    Score: 0.156
  8. Antiviral therapy for neonatal herpes simplex virus: a cost-effectiveness analysis. Am J Manag Care. 1997 Oct; 3(10):1551-8.
    View in: PubMed
    Score: 0.150
  9. Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med. 1996 Sep 01; 125(5):376-83.
    View in: PubMed
    Score: 0.139
  10. The past as prelude to the future: history, status, and future of antiviral drugs. Ann Pharmacother. 1996 Sep; 30(9):967-71.
    View in: PubMed
    Score: 0.139
  11. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J. 1996 Mar; 15(3):247-54.
    View in: PubMed
    Score: 0.134
  12. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis. 1996 Feb; 22(2):341-7.
    View in: PubMed
    Score: 0.134
  13. Unique clinical trial design: combination acyclovir plus prednisone therapy of localized zoster in the normal host. Antiviral Res. 1996 Jan; 29(1):67-8.
    View in: PubMed
    Score: 0.133
  14. Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy. Clin Infect Dis. 2015 Sep 01; 61(5):683-91.
    View in: PubMed
    Score: 0.127
  15. Neonatal herpes simplex virus infections. J Med Virol. 1993; Suppl 1:13-21.
    View in: PubMed
    Score: 0.108
  16. Acyclovir: a decade later. N Engl J Med. 1992 Sep 10; 327(11):782-9.
    View in: PubMed
    Score: 0.106
  17. Neonatal herpes simplex virus infections: pathogenesis and therapy. Pathol Biol (Paris). 1992 Sep; 40(7):729-34.
    View in: PubMed
    Score: 0.105
  18. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group. J Infect Dis. 1992 Mar; 165(3):450-5.
    View in: PubMed
    Score: 0.102
  19. Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12. J Virol. 2012 May; 86(9):5304-13.
    View in: PubMed
    Score: 0.102
  20. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med. 2011 Oct 06; 365(14):1284-92.
    View in: PubMed
    Score: 0.099
  21. Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan; 53(1):6-11.
    View in: PubMed
    Score: 0.098
  22. Natural history and treatment of varicella-zoster in high-risk populations. J Hosp Infect. 1991 Jun; 18 Suppl A:317-29.
    View in: PubMed
    Score: 0.097
  23. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med. 1991 Feb 14; 324(7):444-9.
    View in: PubMed
    Score: 0.095
  24. Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis. Arch Neurol. 1990 Jun; 47(6):646-7.
    View in: PubMed
    Score: 0.090
  25. Chickenpox: where do we stand with treatment? J Pediatr. 1990 Apr; 116(4):587.
    View in: PubMed
    Score: 0.089
  26. Acyclovir: the past ten years. Adv Exp Med Biol. 1990; 278:243-53.
    View in: PubMed
    Score: 0.088
  27. Herpes simplex virus infections of the central nervous system. A review. Am J Med. 1988 Aug 29; 85(2A):61-7.
    View in: PubMed
    Score: 0.080
  28. Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med. 1988 Mar; 108(3):452-4.
    View in: PubMed
    Score: 0.077
  29. Antiviral treatment of a serious herpes simplex infection: encephalitis. J Am Acad Dermatol. 1988 Jan; 18(1 Pt 2):209-11.
    View in: PubMed
    Score: 0.076
  30. The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001. Clin Infect Dis. 2007 Oct 01; 45(7):881-2.
    View in: PubMed
    Score: 0.074
  31. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007 Jan 01; 44 Suppl 1:S1-26.
    View in: PubMed
    Score: 0.071
  32. Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis. Infection. 1987; 15 Suppl 1:S3-8.
    View in: PubMed
    Score: 0.071
  33. Recurrent benign lymphocytic meningitis. Clin Infect Dis. 2006 Nov 01; 43(9):1194-7.
    View in: PubMed
    Score: 0.070
  34. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol. 2006 Mar; 194(3):774-81.
    View in: PubMed
    Score: 0.067
  35. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986 Jan 16; 314(3):144-9.
    View in: PubMed
    Score: 0.067
  36. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis. 2005 Jan; 16(1):7-16.
    View in: PubMed
    Score: 0.062
  37. Therapeutic challenges of neonatal herpes simplex virus infection. Scand J Infect Dis Suppl. 1985; 47:97-106.
    View in: PubMed
    Score: 0.062
  38. Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis. 1984 Sep; 150(3):323-9.
    View in: PubMed
    Score: 0.061
  39. Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: vidarabine versus acyclovir. J Antimicrob Chemother. 1983 Sep; 12 Suppl B:105-12.
    View in: PubMed
    Score: 0.057
  40. Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy. 1983 Sep-Oct; 3(5):275-83.
    View in: PubMed
    Score: 0.057
  41. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001 Aug; 108(2):223-9.
    View in: PubMed
    Score: 0.049
  42. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001 Aug; 108(2):230-8.
    View in: PubMed
    Score: 0.049
  43. Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis. Antiviral Res. 1999 Nov; 44(1):75-8.
    View in: PubMed
    Score: 0.043
  44. Therapeutic approaches to the management of herpes zoster. Adv Exp Med Biol. 1999; 458:159-65.
    View in: PubMed
    Score: 0.041
  45. Approaches to the treatment of varicella-zoster virus infections. Contrib Microbiol. 1999; 3:158-72.
    View in: PubMed
    Score: 0.041
  46. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol. 1998 Oct; 179(4):846-51.
    View in: PubMed
    Score: 0.040
  47. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 1997 Apr 15; 57(8):1502-9.
    View in: PubMed
    Score: 0.036
  48. New therapeutic approaches to the alphaherpesvirus infections. J Antimicrob Chemother. 1997 Feb; 39(2):119-28.
    View in: PubMed
    Score: 0.036
  49. Advances in the management of herpesvirus infections. Introduction. Semin Dermatol. 1996 Jun; 15(2 Suppl 1):1-3.
    View in: PubMed
    Score: 0.034
  50. Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease. Clin Infect Dis. 1995 Oct; 21(4):989-90.
    View in: PubMed
    Score: 0.033
  51. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Infect Dis. 1995 Feb; 20(2):414-20.
    View in: PubMed
    Score: 0.031
  52. Neonatal herpes simplex virus infections: is there a role for immunoglobulin in disease prevention and therapy? Pediatr Infect Dis J. 1994 May; 13(5):432-8; discussion 438-9.
    View in: PubMed
    Score: 0.030
  53. Antiviral therapy: the time has come. J Med Virol. 1993; Suppl 1:1.
    View in: PubMed
    Score: 0.027
  54. Therapeutic approaches to varicella-zoster virus infections. J Infect Dis. 1992 Aug; 166 Suppl 1:S51-7.
    View in: PubMed
    Score: 0.026
  55. Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr. 1992 Apr; 120(4 Pt 1):627-33.
    View in: PubMed
    Score: 0.026
  56. A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med. 1991 Nov 28; 325(22):1539-44.
    View in: PubMed
    Score: 0.025
  57. Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group. J Infect Dis. 1991 Jan; 163(1):17-22.
    View in: PubMed
    Score: 0.023
  58. Varicella-zoster virus infections: chronic disease in the immunocompromised host: evidence for persistent excretion of virus. Pediatr Infect Dis J. 1989 Sep; 8(9):584-5.
    View in: PubMed
    Score: 0.021
  59. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM. Mol Ther. 2009 Jan; 17(1):199-207.
    View in: PubMed
    Score: 0.020
  60. Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial. Am J Med. 1988 Sep; 85(3):301-6.
    View in: PubMed
    Score: 0.020
  61. Yes, brain biopsy should be a prerequisite for herpes simplex encephalitis treatment. Arch Neurol. 1987 Dec; 44(12):1289-90.
    View in: PubMed
    Score: 0.019
  62. Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers. Antimicrob Agents Chemother. 1987 Sep; 31(9):1317-22.
    View in: PubMed
    Score: 0.019
  63. Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan; 56(1):30-6.
    View in: PubMed
    Score: 0.018
  64. Neonatal herpes simplex virus infections. Presentation and management. J Reprod Med. 1986 May; 31(5 Suppl):426-32.
    View in: PubMed
    Score: 0.017
  65. Therapy for human herpesvirus infections. A perspective. Ala J Med Sci. 1985 Apr; 22(2):193-207.
    View in: PubMed
    Score: 0.016
  66. Treatment of human herpesvirus infections with special reference to encephalitis. J Antimicrob Chemother. 1984 Aug; 14 Suppl A:57-74.
    View in: PubMed
    Score: 0.015
  67. Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection. Pediatr Infect Dis. 1984 May-Jun; 3(3):193-5.
    View in: PubMed
    Score: 0.015
  68. Therapeutic approaches to the control of cytomegalovirus infections. Birth Defects Orig Artic Ser. 1984; 20(1):345-52.
    View in: PubMed
    Score: 0.014
  69. Towards therapy and prevention of herpetic infections. Semin Perinatol. 1983 Jan; 7(1):64-81.
    View in: PubMed
    Score: 0.013
  70. Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents. Am J Med. 1982 Jul 20; 73(1A):236-40.
    View in: PubMed
    Score: 0.013
  71. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20; 73(1A):165-71.
    View in: PubMed
    Score: 0.013
  72. Herpes simplex encephalitis and clinical trial design. Lancet. 1982 May 01; 1(8279):1013.
    View in: PubMed
    Score: 0.013
  73. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
    View in: PubMed
    Score: 0.010
  74. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet. 1988 Jan 2-9; 1(8575-6):1-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.